Koronis Biomedical Technologies Corp.

Koronis Biomedical Technologies Corp. (KBT) is a for-profit, Subchapter S Corporation based in Minneapolis, Minnesota, registered in the System for Award Management (SAM) since 2004. The company focuses on developing innovative medical technologies and devices across multiple healthcare domains, with a particular emphasis on creating advanced diagnostic, therapeutic, and assistive technologies that address complex medical challenges. KBT specializes in developing cutting-edge medical devices and digital health solutions that aim to improve patient care, enhance medical treatment methodologies, and provide more effective healthcare interventions.

Through its federal grant awards, KBT has demonstrated expertise in developing sophisticated medical technologies across several critical healthcare areas. The company has received significant project grants from agencies like the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Heart Lung and Blood Institute, and National Institute on Aging. These grants have supported the development of innovative medical technologies, including a smart ankle foot orthosis for diabetic foot ulcer treatment, a portable pulmonary forced oscillation technique device for respiratory assessment, an interactive gaming platform for cognitive interventions in dementia patients, a renal replacement therapy machine for pediatric patients, and an inhaler training system for chronic obstructive pulmonary disease (COPD) patients. KBT's projects consistently demonstrate a commitment to addressing unmet medical needs, leveraging technology to improve patient outcomes, and creating solutions that can potentially reduce healthcare complications and improve quality of life for patients with complex medical conditions.